Pre-market
Sale
Calculated transaction value
$830.9K

Milne George M Jr Director

Transaction date Oct 5, 2026
Public filing date Oct 7, 2026
Filing lag Filed 2 days later

AMLX daily price context

Close on/before transaction
$27.78 Oct 5, 2026
First close after public filing
$27.2 Oct 8, 2026
Return after filing · so far
+3.46% Through Oct 9, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
30,000 shares @ $27.7
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001193125-26-416950
Filing cohort

Transactions in this filing

Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$830.9K
Buys / sales
0 / 1
Transactions reported in the same official filing
Issuer Transaction Traded Value
Amylyx Pharmaceuticals, Inc. AMLX Current Sale Oct 5, 2026 $830.9K